Free Trial
OTC:FPHAF

Faron Pharmaceuticals Oy (FPHAF) Stock Price, News & Analysis

$3.30 0.00 (0.00%)
As of 05/12/2023

About Faron Pharmaceuticals Oy Stock (OTC:FPHAF)

Key Stats

Today's Range
$3.30
$3.30
50-Day Range
$3.30
$3.30
52-Week Range
$3.10
$6.00
Volume
N/A
Average Volume
3,650 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. It also develops Haematokine, an investigational AOC3 inhibitor that is used for regenerative medicines in hematological malignancies, as well as chemotherapy induced suppression of the bone marrow. In addition, the company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.

Receive FPHAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Faron Pharmaceuticals Oy and its competitors with MarketBeat's FREE daily newsletter.

FPHAF Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Faron Pharmaceuticals Expands Cancer Study to UK
See More Headlines

FPHAF Stock Analysis - Frequently Asked Questions

Faron Pharmaceuticals Oy's stock was trading at $3.30 at the start of the year. Since then, FPHAF stock has increased by 0.0% and is now trading at $3.30.
View the best growth stocks for 2025 here
.

Shares of FPHAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTC
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTC:FPHAF
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTC:FPHAF) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners